Jaffetilchin Investment Partners, LLC Amgen Inc Transaction History

Jaffetilchin Investment Partners, LLC

$1.3 Billion
Q3 2024

A detailed history of Jaffetilchin Investment Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Jaffetilchin Investment Partners, LLC holds 2,185 shares of AMGN stock, worth $643,548. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,185

Previous 1,876 16.47%

Holding current value

$643,548

Previous $586,000 20.14%

% of portfolio

0.05%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$309.38 - $337.38 $95,598 - $104,250	309 Added 16.47%	2,185 $704,000
Q2 2024 Jul 30, 2024	BUY	$262.75 - $319.31 $11,035 - $13,411	42 Added 2.29%	1,876 $586,000
Q1 2024 May 16, 2024	SELL	$268.87 - $324.56 $576,726 - $696,181	-2,145 Reduced 53.91%	1,834 $521,000
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $46,537 - $52,499	182 Added 4.79%	3,979 $1.15 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $455,885 - $565,994	2,085 Added 121.79%	3,797 $1.02 Million
Q2 2023 Aug 15, 2023	SELL	$214.27 - $253.37 $57,424 - $67,903	-268 Reduced 13.54%	1,712 $380,000
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $248,594 - $302,995	1,101 Added 125.26%	1,980 $478,000
Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $201,317 - $255,797	879 New	879 $230,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $11,996 - $13,350	52 Added 1.42%	3,724 $906,000
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $380,652 - $421,101	1,736 Added 89.67%	3,672 $898,000
Q4 2021 Feb 17, 2022	BUY	$198.88 - $227.6 $112,168 - $128,366	564 Added 41.11%	1,936 $436,000
Q3 2021 Oct 25, 2021	BUY	$212.27 - $248.7 $23,774 - $27,854	112 Added 8.89%	1,372 $292,000
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $231,477 - $256,807	-991 Reduced 44.02%	1,260 $307,000
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $82,106 - $95,682	-370 Reduced 14.12%	2,251 $560,000
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $16,444 - $19,582	76 Added 2.99%	2,621 $603,000
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $53,969 - $60,018	230 Added 9.94%	2,545 $647,000
Q2 2020 Aug 03, 2020	BUY	$197.81 - $242.74 $451,798 - $554,418	2,284 Added 7367.74%	2,315 $546,000
Q2 2020 Jul 31, 2020	BUY	$197.81 - $242.74 $6,132 - $7,524	31 New	31 $546,000
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $282,942 - $330,284	-1,586 Closed	0 $0
Q3 2018 Oct 05, 2018	BUY	$185.29 - $208.89 $11,117 - $12,533	60 Added 3.93%	1,586 $329,000
Q2 2018 Aug 01, 2018	BUY	$166.05 - $186.51 $253,392 - $284,614	1,526 New	1,526 $282,000
Q4 2017 Jan 10, 2018	SELL	$168.79 - $188.59 $611,188 - $682,884	-3,621 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$167.29 - $191.0 $605,757 - $691,611	3,621	3,621 $675,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jaffetilchin Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jaffetilchin Investment Partners, LLC with notifications on news.

Account

Jaffetilchin Investment Partners, LLC Amgen Inc Transaction History